Literature DB >> 28462746

Disinfectant Susceptibility Profiling of Glutaraldehyde-Resistant Nontuberculous Mycobacteria.

Winona Burgess1, Alyssa Margolis1, Sara Gibbs1, Rafael Silva Duarte2, Mary Jackson1.   

Abstract

OBJECTIVE Activated alkaline glutaraldehyde (GTA) remains one of the most widely used high-level disinfectants worldwide. However, several reports have highlighted the potential for nontuberculous mycobacteria to develop high-level resistance to this product. Because aldehyde resistance may lead to cross-resistance to other biocides, we investigated the susceptibility profile of GTA-resistant Mycobacterium chelonae and M. abscessus isolates to various disinfectant chemistries. METHODS High-level disinfectants commonly used in the reprocessing of endoscopes and other heat-sensitive, semicritical medical equipment, including different formulations of aldehyde-based products and oxidizing agents, were tested against 10 slow- and fast-growing, GTA-susceptible and GTA-resistant, Mycobacterium isolates in suspension tests and carrier tests at different temperatures. RESULTS While peracetic acid- and hydrogen peroxide-based disinfectants (S40, Resert XL, Reliance DG) efficiently killed all of the Mycobacterium isolates, GTA- and ortho-phthalaldehyde-based products (ie, Cidex, Aldahol, Cidex OPA) showed variable efficacy against GTA-resistant strains despite the ability of some formulations (Aldahol) to overcome the resistance of some of these isolates, especially when the temperature was increased from 20°C to 25°C. CONCLUSIONS Application permitting, oxidizing chemistries may provide a safe alternative to aldehyde-based products, particularly in GTA-resistant mycobacterial outbreaks. Infect Control Hosp Epidemiol 2017;38:784-791.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28462746      PMCID: PMC5507614          DOI: 10.1017/ice.2017.75

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  24 in total

Review 1.  Nosocomial infections due to nontuberculous mycobacteria.

Authors:  M S Phillips; C F von Reyn
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

2.  Glutaraldehyde resistant mycobacteria from endoscope washers.

Authors:  B van Klingeren; W Pullen
Journal:  J Hosp Infect       Date:  1993-10       Impact factor: 3.926

3.  Efficacy of peroxygen compounds against glutaraldehyde-resistant mycobacteria.

Authors:  P M Stanley
Journal:  Am J Infect Control       Date:  1999-08       Impact factor: 2.918

4.  Aldehyde-resistant mycobacteria bacteria associated with the use of endoscope reprocessing systems.

Authors:  Christopher W Fisher; Anthony Fiorello; Diana Shaffer; Mary Jackson; Gerald E McDonnell
Journal:  Am J Infect Control       Date:  2012-02-10       Impact factor: 2.918

5.  Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers.

Authors:  G Bolan; A L Reingold; L A Carson; V A Silcox; C L Woodley; P S Hayes; A W Hightower; L McFarland; J W Brown; N J Petersen
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

6.  Aldahol high-level disinfectant.

Authors:  Norman Miner; Valerie Harris; Thuy Dung Cao; Towanda Ebron; Natalie Lukomski
Journal:  Am J Infect Control       Date:  2009-11-08       Impact factor: 2.918

7.  Analysis of a panel of rapidly growing mycobacteria for resistance to aldehyde-based disinfectants.

Authors:  Mary Ann De Groote; Sara Gibbs; Vinicius Calado Nogueira de Moura; Winona Burgess; Kris Richardson; Shannon Kasperbauer; Nancy Madinger; Mary Jackson
Journal:  Am J Infect Control       Date:  2014-08       Impact factor: 2.918

8.  Antibiotic susceptibility of glutaraldehyde-tolerant Mycobacterium chelonae from bronchoscope washing machines.

Authors:  Kazuyo Nomura; Midori Ogawa; Hiroshi Miyamoto; Tetsuro Muratani; Hatsumi Taniguchi
Journal:  Am J Infect Control       Date:  2004-06       Impact factor: 2.918

9.  Nosocomial infection and pseudoinfection from contaminated endoscopes and bronchoscopes--Wisconsin and Missouri.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1991-10-04       Impact factor: 17.586

10.  Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.

Authors:  Zuzana Svetlíková; Henrieta Skovierová; Michael Niederweis; Jean-Louis Gaillard; Gerald McDonnell; Mary Jackson
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

View more
  6 in total

Review 1.  Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.

Authors:  Matt D Johansen; Jean-Louis Herrmann; Laurent Kremer
Journal:  Nat Rev Microbiol       Date:  2020-02-21       Impact factor: 60.633

2.  Identification and Characterization of Nasal Polyposis and Mycoplasma Superinfection by Scanning Electron Microscopy and Nasal Cytology with Optical Microscopy: A Case Report.

Authors:  Arturo Armone Caruso; Veronica Viola; Salvatore Del Prete; Sabato Leo; Daniela Marasco; Andrea Fulgione; Daniele Naviglio; Monica Gallo
Journal:  Diagnostics (Basel)       Date:  2019-11-04

Review 3.  Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design.

Authors:  Kia C Ferrell; Matt D Johansen; James A Triccas; Claudio Counoupas
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

4.  Tolerance to Glutaraldehyde in Escherichia coli Mediated by Overexpression of the Aldehyde Reductase YqhD by YqhC.

Authors:  Beatriz Merchel Piovesan Pereira; Muhammad Adil Salim; Navneet Rai; Ilias Tagkopoulos
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

5.  The Research Gap in Non-tuberculous Mycobacterium (NTM) and Reusable Medical Devices.

Authors:  Jon W Weeks; Katharine Segars; Suvajyoti Guha
Journal:  Front Public Health       Date:  2020-08-20

Review 6.  MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections.

Authors:  Jigar P Sethiya; Melanie A Sowards; Mary Jackson; Elton Jeffrey North
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.